Fortis Healthcare Limited — Important, 20-12-2024: General Updates

Fortis Healthcare Limited has acquired 5,970,149 equity shares, representing a 7.61% stake in Agilus Diagnostics Limited, a material subsidiary, from the International Finance Corporation (IFC). This strategic acquisition, completed at a price of INR 719.2 per share, amounts to an aggregate consideration of approximately INR 429.37 crore. This move aligns with the previously established shareholders' agreement, enabling Fortis to further expand its footprint in the diagnostics industry. Agilus, which generated standalone revenues of approximately INR 85,880.88 lakh for the year ended March 31, 2024, operates a large network of 407 labs across India and has a presence in Dubai and Nepal. The acquisition presents a positive outlook for Fortis, enhancing its operational capabilities and market positioning in a growing sector. Investors should watch closely as the company continues to strengthen its shareholding in Agilus, paving the way for potential growth and synergies.